International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 650

PDF Downloaded: 277


Get Permission Almeida, Surana, Christy, Jatale, and Ramchandani: Relevance of allergen specific immunoglobulin e testing in Indian population: A retrospective study


Introduction

Allergy is a disorder of the human immune system which causes an abnormal or intense reaction to any harmless substance present in the environment.1 T2 helper white blood cells on contact with an allergen, produce Immunoglobulin E (IgE) antibody which is specific to a particular allergen. Re-exposure to the same allergen, triggers the release of inflammatory chemicals such as histamines, leukotrienes leading to allergy symptoms. Allergic reactions are characterized by the involvement of allergen specific IgE in anaphylaxis, allergic rhinitis, some food allergies, and allergic asthma.2 Prevalence of allergic disease in India is 20 to 30% of the total population and mainly comprises of asthma, rhinitis, drug, food and insect allergy, eczema and urticaria. Prevalence of bronchial asthma was found to be 2.05% as per Indian study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis (INSEARCH).1 Besides asthma, there is a rising trend of atopic rhinitis, anaphylaxis, drug, food and insect allergy, eczema, urticaria, and angioedema in India.3 Certain studies showed that IgE-mediated food allergy affects as many as 6-8% children and 3-4% of adults.4 Prevalence of atopic dermatitis in adults was found to be 10.2%.5 Not all of the risk factors for allergy are known, but genetic and environmental factors are of importance besides lifestyle factors.6 Some common triggers for inhalant allergies are advancing age, smoking, tobacco exposure, family history of asthma, use of cooking fuels indoor allergens, outdoor allergens and air pollution.1, 7 Asthma management in India remains poor leading to higher morbidity and a poor quality of life. 40-50% of paediatric asthma cases in India are uncontrolled or severe.8

Total IgE is used as a screening test for allergy. Its elevated levels are seen in allergic as well as non-allergic diseases. When combined with allergen specific IgE, it gives a comprehensive testing solution.6 However, Total IgE has a low diagnostic efficiency, therefore ImmunoCAP ImmunoCAP Phadiatop is used as a screening method for patients without a history of allergy thus reducing the number of patients that must be referred for allergen-specific diagnostic testing.9 Phadiatop is a qualitative assay and indicates whether patients are IgE sensitized with common inhalant allergens. Phadiatop has a high efficiency in screening of patients without a history of allergy to confirm diagnosis of atopy thus reducing the number of patients referred for allergen specific testing.9 Immuno CAP can be performed irrespective of a patient’s age, skin condition, medication, symptom, disease activity, pregnancy, and even in early infancy.

India is the most diverse country in the world with respect to religions, languages, food, clothes, races, tribes, socioeconomic strata, diet and climate. Though the incidence of allergic disorders is rising alarmingly, the number of studies done is not adequate. In view of limited data as well as studies pertaining to Allergic testing in Indian subcontinent, it is important to understand and review the various factors which may help the Clinicians decide the timely future course of action. In our retrospective study, we reviewed the positivity of specific IgE allergens in Indian Population. We have majorly focused on the allergen groups and how this information can be used to address health concerns in adults and children. Comparison between total and specific IgE was analysed along with quantification of IgE antibodies in the diagnosis of allergic patients. It is necessary to make this comparative assessment for better understanding of impact of allergies. Identifying the causative allergen can help in early diagnosis and management of the disease.

Materials and Methods

This retrospective study was conducted at Global Reference Laboratory, Mumbai, Maharashtra, India, from May 2020 to May 2022 from the data available in Laboratory Information System (LIS) of the laboratory.

The approval was obtained to use this Laboratory Information Management System (LIMS) data for publication from Independent Ethics Committee.

Inclusion criteria

Total available data of 65431 patients from May 2020 to May 2022 tested for various tests (Total IgE, Phadiotop, and specific IgE either all tests performed or tested in specific combinations) were included Total IgE in serum was analyzed on Roche Cobas 8000 by Electro chemiluminescence (ECLIA). Serum samples from all patients including children and adults were analysed for allergen– specific IgE antibodies using the Thermo Scientific ImmunoCAP specific IgE Test on Phadia 250 analyser. Individual allergens belonging to animal allergy, dust allergy, drug allergy, food allergy, pollen grass group, micro-organism allergen group, tree pollen and weed pollen group were tested.

The results were interpreted as follows.

  1. The Total IgE concentration in healthy, non-atopic subjects is greatly dependent on age.

  2. ImmunoCAP Phadiatop screening a positive result is >0.35 Kilo allergy unit per litre (kUA/L). A negative result indicates that the symptoms are not due to common food and inhalant allergies and other differential diagnoses must be considered. Individual allergens are reported as Quantitative. Cut-off of quantitative result is 0.10 (kUA/L).10

Table 0

Age

IU/mL

Neonates

< 1.5

Infants in 1st year of life

<15

Children aged 1-5 years

< 60

Children aged 6-9 years

< 90

Children aged 10-15 years

< 200

Adults

< 100

Data analysis

The data was analysed using “R Studio version 1.4.1103”. Descriptive analyses were made to obtain the frequency and percentage of age group, gender, IgE total Antibody and specific allergens. Chi Square test were used to obtain association of age group, gender, and specific allergens with IgE total antibody. Similarly, gender comparison of specific Allergens was done using Chi Square test and Fisher Exact t test. A two-sided p value of <0.05 was statistically significant.

Results

Overall demographic distribution

Of the total 65431 patients, 34601 (52.88%) were females and 30830 (47.12%) were males. 7114 (10.87%) were children up to 12 years and 18699 (28.58%) were above 50 years of age. (Table 2).

Table 1

Demographic distribution

Age Group

Sex

Female

Male

Total

N

%

N

%

N

%

0-3

768

39.16%

1193

60.84%

1961

3.00%

4-6

715

39.97%

1074

60.03%

1789

2.73%

7-12

1382

41.08%

1982

58.92%

3364

5.14%

13-19

2307

48.21%

2478

51.79%

4785

7.31%

20-29

6293

54.00%

5361

46.00%

11654

17.81%

30-39

7184

56.55%

5519

43.45%

12703

19.41%

40-49

6073

57.98%

4401

42.02%

10474

16.01%

>50

9878

52.83%

8821

47.17%

18699

28.58%

Not given

1

-

1

-

2

-

Total

34601

52.88%

30830

47.12%

65431

100.00%

[i] N=Number of participants, % =Percentage

Table 2

Age and gender wise distribution of total IgE

IgE Total antibody

Negative

Positive

p value

N

%

N

%

Age Group

0-3

385

26.74%

1055

73.26%

<0.0001

4-6

273

19.42%

1133

80.58%

7-12

659

24.80%

1998

75.20%

13-19

782

20.84%

2971

79.16%

20-29

1909

20.94%

7209

79.06%

30-39

2473

24.77%

7512

75.23%

40-49

2275

28.24%

5780

71.76%

>50

3769

28.95%

9251

71.05%

Gender

Female

7909

29.63%

18781

70.37%

<0.0001

Male

4616

20.30%

18128

79.70%

Total

12525

25.33%

36909

74.66%

[i] N=Number of participants, % = Percentage, p<0.05 is considered statistically significant

Table 3

Overall specific IgE levels

Specific IgE & Allergy panel

Negative

Positive

Total

   % Positive

Food Allergen

3122

3352

6474

51.78%

Dust Allergen

1427

2346

3773

62.18%

Grass Pollen Allergen

1782

985

2767

35.60%

Tree pollen Allergen

1444

804

2248

35.77%

Weed pollen Allergen

1301

1040

2341

44.43%

Micro-organism Allergen

5901

5586

11487

48.63%

Drug Allergen

1241

14

1255

1.12%

Animal Allergen

2541

875

3416

25.61%

Insect Allergen

1247

1389

2636

52.69%

Phadiatop allergen screening - Infant

64

69

133

51.88%

Phadiatop Allergen screening - Adult

2846

3036

5882

51.62%

Table 4

Positivity of specific causative allergens

Specific IgE Allergens

Negative

Positive

Total

% Positive

Food

Allergen-Crab (Cancer pagurus)

2

7

9

77.78%

Allergen-Lobster (Homarus gammarus)

2

2

4

50.00%

Allergen-Shrimp / Prawns

1374

1242

2616

47.48%

Allergen-Banana (Kela / Musa Spp.)

233

140

373

37.53%

Allergen-Wheat (Gehon / Triticum aestivum)

2927

1379

4306

32.03%

Allergen-White Bean (Phaseolus vulgaris)

92

43

135

31.85%

Allergen-Chick Pea (Kabuli Chana / Cicer arietinus)

271

125

396

31.57%

Allergen-Cow Milk (Doodh)

3448

1568

5016

31.26%

Allergen-Spinach (Palak / Spinachia oleracea)

277

124

401

30.92%

Allergen-Garlic (Lehsoon / Allium Sativum)

888

374

1262

29.64%

Allergen-Pistachio

56

23

79

29.11%

Allergen-Corn (Maize / Makka / Zea Mays)

322

132

454

29.07%

Allergen-Pineapple (Ananas)

1242

505

1747

28.91%

Allergen-Lemon (Nimbu / Citrus limon)

1254

491

1745

28.14%

Allergen-Lentil (Masoor Dal / Lens esculenta)

1362

522

1884

27.71%

Allergen - Brinjal (Aubergine, eggplant / Solanum melongena)

241

91

332

27.41%

Allergen-Almond (Badam / Amygdalus communis)

547

200

747

26.77%

Allergen-Papaya (Carica papaya)

134

48

182

26.37%

Allergen-Green Pea

107

38

145

26.21%

Allergen-Peanut (Moongfali / Arachis hypogaea)

3130

1097

4227

25.95%

Allergen-Walnut (Juglans californica)

153

52

205

25.37%

Allergen-Tomato (Tamatar / Lycopersicon lycopresicum)

1460

496

1956

25.36%

Allergen-Onion (Piaz / Allium cepa)

921

303

1224

24.75%

Allergen-Egg White (Anda)

2831

927

3758

24.67%

Allergen-Soyabean (Glycine max)

3115

1014

4129

24.56%

Allergen-Cabbage (Gobi / Brassica oleraceavar.Capitata)

300

95

395

24.05%

Allergen-Paprica (Simla Mirchi / Capsicum annuum)

272

86

358

24.02%

Allergen-Chilipepper Capsicum frutescens

19

6

25

24.00%

Allergen-Orange (santra / Citrus sinensis)

92

29

121

23.97%

Allergen-Peach (Prunus persica)

271

85

356

23.88%

Allergen-Coconut (Narial /Cocos nucifera)

549

171

720

23.75%

Allergen-Coffee

13

4

17

23.53%

Allergen-Hazelnut (Corylus avellana)

278

84

362

23.20%

Allergen-Gluten

439

131

570

22.98%

Allergen- Celery (Apium graveolens)

210

59

269

21.93%

Allergen-Apple (Safarchand / Malus X Domestica)

290

81

371

21.83%

Allergen-Beef Cow meat (Bos spp.)

1043

288

1331

21.64%

Allergen-Rape Pollen (Sarson / Brassica napus)

124

34

158

21.52%

Allergen-Cashew (Nut Kaju / Anacardium occidentale)

350

90

440

20.45%

Allergen-Potato (Aaloo / Solanum tuberosum)

803

205

1008

20.34%

Allergen-Baingan

12

3

15

20.00%

Allergen-Rice (Chawal / Oryza sativa)

1698

424

2122

19.98%

Allergen-Pear (Pyrus communis)

189

47

236

19.92%

Allergen-Mutton (Ovis Spp.)

89

22

111

19.82%

Allergen-Kiwi Fruit (Actinidia deliciosa)

26

6

32

18.75%

Allergen-Mushroom champignon / Agaricus hortensis

14

3

17

17.65%

Allergen-Blue Mussel (Mytilus Edulis)

2040

434

2474

17.54%

Allergen-Pecan nut (Carya Illinoensis)

147

30

177

16.95%

Allergen-Baker’s Yeast (Saccharomyces cerevisiae)

248

49

297

16.50%

Allergen-Chicken Meat (Murgi)

1133

214

1347

15.89%

Allergen-Casein (Milk Protein / Dahi)

417

76

493

15.42%

Allergen-Mustard (Sarson / Brassica / Sinapsis Spp.)

39

7

46

15.22%

Allergen-Pork (Pig meat)

1104

192

1296

14.81%

Allergen-Olive (Olea europaea)

1463

252

1715

14.69%

Allergen-Brazil Nut (Bertholletia excelsa)

303

51

354

14.41%

Allergen-Mango (Mangifera indica)

27

4

31

12.90%

Allergen-Plaice Fish (Pleuronectes platessa)

109

16

125

12.80%

Allergen-Egg Yolk (Anda)

1186

167

1353

12.34%

Allergen-Black Pepper Piper nigrum

37

5

42

11.90%

Allergen-Tuna Fish (Pleuronectes platessa)

1193

158

1351

11.70%

Allergen-Cheese Cheddar

231

30

261

11.49%

Allergen-Cod Fish (Machhli / Gadus morhua)

2928

337

3265

10.32%

Allergen-Salmon (Rawas fish / Salmo salar)

1208

139

1347

10.32%

Allergen-Clove (Syzygium aromaticum)

18

2

20

10.00%

Allergen-Basil Ocimum Basilicum

19

2

21

9.52%

Allergen-Cocoa (Chocolate / Theobroma cacao)

230

24

254

9.45%

Allergen-Alpha -Lactalbumin (Milk protein)

267

0

267

0.00%

Allergen-Beta - Lactoglobulin- Milk (Milk protein)

267

0

267

0.00%

Allergen-Cardamon (Elettaria cardamomum)

21

0

21

0.00%

Allergen-Coriander

22

0

22

0.00%

Allergen-Strawberry (Fragaria vesca)

1

0

1

0.00%

Dust

Allergen-Dermatophagoides Pteronyssinus (House Dust Mite)

1032

1479

2511

58.90%

Allergen - Dermatophagoides Farinae (House Dust Mite)

1538

2135

3673

58.13%

Allergen-House dust Greer Labs

1071

1147

2218

51.71%

Allergen - Hollister-stier Labs house dust

39

36

75

48.00%

Grass Pollen

Allergen- Johnson Grass (Jowar grass / Sorghum Grass)

1085

523

1608

32.52%

Allergen- Bermuda Grass (Durva / Cynodon grass)

1858

878

2736

32.09%

Allergen- Cultivated Rye grass (Secale cereale)

268

104

372

27.96%

Allergen- Meadow Grass (Poa pratensis)

375

132

507

26.04%

Allergen- Timothy Grass (Ghass / Phleum pratense)

255

84

339

24.78%

Tree Pollen

Allergen- Oak Quercus Alba

372

180

552

32.61%

Allergen- Papdi Chibil / Elm

1357

625

1982

31.53%

Allergen-Mesquite (Pahadi Keekar / Prosopis Juliflora)

1010

435

1445

30.10%

Allergen-Eucalyptus (Nilgiri / Safeda)

87

32

119

26.89%

Allergen- Willow Salix Caprea

11

4

15

26.67%

Allergen-Acasia Babool (Acasia Longifolia)

88

31

119

26.05%

Allergen-Birch (Betula verrucosa)

1202

355

1557

22.80%

Allergen-Alder (Alnus Incana)

1179

345

1524

22.64%

Allergen-White Pine (Pinus strobus)

20

2

22

9.09%

Allergen- Mulberry Shahtoot (Morus alba)

21

2

23

8.70%

Weed Pollen

Allergen-Goose Foot (Chenopodium Album)

708

566

1274

44.43%

Allergen-Common Ragweed (Close To Parthenium / Congress Grass / Ambrosia Elatior)

1450

857

2307

37.15%

Allergen-Cocklebur Xanthium commune

13

7

20

35.00%

Allergen-Mugwort (Sita Bani / Artemisia vulgaris / BanoBarna)

1031

489

1520

32.17%

Allergen-English Plantain (Plantago lanceolata)

88

39

127

30.71%

Allergen- Common Pigweed (Kaantewali Chauli / Amaranthus Retroflexus)

1092

430

1522

28.25%

Fungus

Allergen-Aspergillus Fumigatus (Fungus)

6140

5261

11401

46.15%

Allergen-Candida Albicans (Fungus)

1026

510

1536

33.20%

Allergen-Penicillium Notatum (Fungus / Penicillium chrysogenum)

1611

287

1898

15.12%

Allergen-Alternaria alternata (fungus)

1816

297

2113

14.06%

Allergen-Cladosporium herbarum (Fungus)

647

105

752

13.96%

Drug

Allergen-Insulin Human

5

2

7

28.57%

Allergen-Penicilloyl V (Antibiotic)

41

11

52

21.15%

Allergen-Penicilloyl G (Antibiotic)

95

13

108

12.04%

Allergen-ACTH

69

2

71

2.82%

Allergen-Amoxicillin (Antibiotic)

41

0

41

0.00%

Allergen-Ampicillin (Antibiotic)

12

0

12

0.00%

Allergen-Cephalosporin (Antibiotic)

52

0

52

0.00%

Allergen-Ciprofloxacin (Antibiotic)

50

0

50

0.00%

Allergen-Diclofenac (pain killer)

872

0

872

0.00%

Allergen-Ibuprofen (Pain killer)

857

0

857

0.00%

Allergen-Paracetamol

900

0

900

0.00%

Allergen-Sulpha (Antibiotic)

97

0

97

0.00%

Animal

Allergen-Cow Dander

229

89

318

27.99%

Allergen-Dog Dander

2359

795

3154

25.21%

Allergen-Cat Dander

2427

394

2821

13.97%

Allergen-Horse Dander

271

42

313

13.42%

Allergen-Guinea Pig Epithelium

8

1

9

11.11%

Allergen-Animal Pigeon Feathers

207

0

207

0.00%

Insects

Allergen-Mosquito (Machhar /Aedes communis)

6

9

15

60.00%

Allergen-Cockroach German (Blatella germanica)

1239

1374

2613

52.58%

Allergen-Honey Bee Venom (Madhu Makhhi / Apis mlifera)

9

9

18

50.00%

Phadiatop

Phadiatop allergen screening - Infant

64

69

133

51.88%

Phadiatop Allergen screening - Adult

2846

3036

5882

51.62%

Total Tests

89374

38303

127682

30

Total IgE distribution

A total of 49434 patients tested for IgE total antibodies were divided into different age groups depending on their normal/abnormal values. High IgE levels were seen in 36909 (74.66%) patients and normal IgE levels were seen in 12525 (25.33%) (Table 3)

Overall positivity among the patients

Dust allergy was the most prevalent (62.18%) followed by Insect allergy (52.69%) and food allergy (51.78%). (Table 4)

Among those tested for specific allergens, overall, 30% were positive for allergies.

Even among the dust allergies, house dust mite (58.90%) was seen to be most common. Among the insect allergy group, mosquito had the highest positive rate of 60% followed by Cockroach (52.58%). (Table 5)

Age wise prevalence of allergy

Incidence of food allergy was highest in the 0-3year age group. Amongst these, egg yolk allergies were highest (26.95%) followed by cow milk (25.51%). Food allergens such as Plaice fish (31.25%) and Pecan nut caused the highest allergy amongst 7-12 year age group. In fungal Allergy, Penicillium Notatum fungus is more prevalent (20.21%) in the 20-29 years age group. Incidence of House dust mite (Dermatophagoides Farinae) allergy was 16.77% and house dust hollister was 25% in 20-29 years age group. (Table 6)

Table 5

Age wise prevalence of allergens

p value

Age in years

0-3

4-6

7-12

13-19

20-29

30-39

40-49

>50

Allergen Group

N

%

N

%

N

%

N

%

N

%

N

%

N

%

N

%

Allergen-Cow Milk

Positive

400

25.51%

244

15.56%

216

13.78%

113

7.21%

156

9.95%

138

8.80%

113

7.21%

188

11.99%

<0.0001

Allergen-Egg Yolk

Positive

45

26.95%

31

18.56%

21

12.57%

18

10.78%

14

8.38%

6

3.59%

11

6.59%

21

12.57%

<0.0001

Allergen-Plaice Fish

Positive

1

6.25%

0

0.00%

5

31.25%

3

18.75%

1

6.25%

0

0.00%

1

6.25%

5

31.25%

0.0235

Allergen-Pecan nut

Positive

4

13.33%

3

10.00%

9

30.00%

5

16.67%

5

16.67%

1

3.33%

1

3.33%

2

6.67%

0.0054

Dust Allergen

Positive

137

5.84%

167

7.12%

330

14.07%

252

10.74%

402

17.14%

388

16.54%

248

10.57%

422

17.99%

<0.0001

Dermatophagoides Farinae (House Dust Mite)

Positive

129

6.04%

155

7.26%

315

14.75%

229

10.73%

358

16.77%

342

16.02%

231

10.82%

376

17.61%

<0.0001

Hollister-stier Lab’s house dust

Positive

0

0.00%

1

2.78%

3

8.33%

7

19.44%

9

25.00%

4

11.11%

4

11.11%

8

22.22%

0.1442

Penicillium Notatum ( Fungus)

Positive

8

2.79%

12

4.18%

37

12.89%

30

10.45%

58

20.21%

41

14.29%

45

15.68%

56

19.51%

0.0015

[i] N = Number of participants, % = Percentage p<0.05 is considered statistically significant

Comparison of specific IgE and total IgE results

The comparative analysis of Total IgE and specific IgE showed that while Total IgE as well as specific IgE was raised in some patients, some patients with normal Total IgE levels showed raised specific IgE levels for specific allergens. (Table 7)

Table 6

Comparison of specific IgE and total IgE results in all patients

Specific Allergens

Total antibody IgE

Negative

Positive

N

%

N

%

p value

Food

Negative

989

57.04%

745

42.96%

<0.0001

Positive

349

13.66%

2206

86.34%

Dust

Negative

610

54.76%

504

45.24%

<0.0001

Positive

192

10.34%

1664

89.66%

Grass Pollen

Negative

618

39.67%

940

60.33%

<0.0001

Positive

67

7.60%

814

92.40%

Tree pollen

Negative

472

37.64%

782

62.36%

<0.0001

Positive

64

8.90%

655

91.10%

Weed pollen

Negative

469

43.47%

610

56.53%

<0.0001

Positive

66

7.32%

836

92.68%

Micro organism

Negative

631

37.88%

1035

62.12%

<0.0001

Positive

78

7.41%

975

92.59%

Drug

Negative

21

23.86%

67

76.14%

Animal

Negative

701

36.89%

1199

63.11%

<0.0001

Positive

27

4.07%

637

95.93%

Insect

Negative

561

45.87%

662

54.13%

<0.0001

Positive

118

8.75%

1231

91.25%

Phadiatop Allergen screening - Infant

Negative

2

40.00%

3

60.00%

<0.0001

Positive

0

0.00%

5

100.00%

Phadiatop Allergen screening - Adult

Negative

646

49.85%

650

50.15%

<0.0001

Positive

115

7.47%

1424

92.53%

[i] N= Number of participants, % = Percentage, p<0.05 is considered statistically significant

Number of specific IgE allergens in patients

Out of the 18377 patients tested for specific allergens, 7340 (39.94%) had at least one allergen positive. 667 patients (3.63%) were positive for two allergens. 393 patients (2.14%) were positive for three allergens. 202 patients (1.10%) had eight allergens detected. (Table 8)

Table 7

Count of positive allergens in patients

Count of Allergy Positive

N

%

0

8862

48.22%

1

7340

39.94%

2

667

3.63%

3

393

2.14%

4

289

1.57%

5

200

1.09%

6

202

1.10%

7

222

1.21%

8

202

1.10%

Total

18377

100%

[i] N= Number of participants, % = Percentage, p<0.05 is considered statistically significant

Discussion

Allergic disorders have been showing an increasing trend in the world. The upsurge in allergies is observed as societies become more affluent and urbanized. It is not easy to distinguish which allergen is causing the clinical symptoms. A test should be able to identify the allergic condition along with disease causing allergen. Symptoms are not just dependent on IgE but also on plethora of factors. Currently there is no gold standard for clinical diagnosis of allergic reactions. Barring a few allergy specialists who still are dependent on skin prick tests, most of the physicians use screening tests like Total IgE, ImmunoCAP Phadiatop screening and specific IgE tests against allergens, along with symptoms for clinical decisions.11

In our study, among those tested for specific allergens, overall, 30% were positive for allergies. In a similar study done on Jordanian cohort by Khasawneh R et al., prevalence of 20% was reported.6 This was in agreement with another study conducted in South India by Nitin Joseph et al. where 28.7% of the participants reported having allergies.12 Another Indian Study by Prasad R et al claimed that 20% to 30% of the population suffered from allergic disorders.1 Contrary to above mentioned studies, a Swedish study done by Enroth et al. has reported 42.3% positivity of allergy based on self-reporting by patients.12, 13 Similarly, self-reporting by patients has shown an increase of 41.7% allergies in an American study by Seite S et al.14

In our study, the allergy testing was found to be slightly higher in women (52.88%) as compared to men (47.11%). As per an American study by National Health and Nutrition Examination (NHANES) women tend to self-document poor health and notice symptoms earlier than men.14 As per study done in Vienna by Erika Jenson et al., women are more prone to develop allergies due to hormonal interactions. (18). Another study by Eva Untersmayr et al. also mentions that female sexual hormones elevate the risk for allergy. 15

39.94% patients had at least one allergen positive while 3.63% patients were positive for two allergens in our study. This was in accordance with an American study by National Health and Nutrition Examination (NHANES) where 44.6% of patients had at least 1 allergen positive.14 This describes the demographic distribution of allergic disorders and proves burden of allergic disorders is not lesser.

In our retrospective study, the positive rate of Total IgE among all age groups was 74.66%. The positive rate of Total IgE with Specific IgE was found to be between 75-95.9%, while 4-13.66% was found to be negative for Total IgE but positive for Specific IgE. As per study done in China by Man-Li Chang, 65% patients showed an increase in Total IgE. However positive correlation between IgE and Specific IgE was only 29% in their study contrary to our results.16 Probable reason for this, is allergic disease being more probable when Specific IgE is high. However, increase in Total IgE is not specific for allergy and can be high in parasitic infections, multiple myeloma, liver disease and rheumatoid arthritis as well.16

To understand whether specific IgE is better than Total IgE or vice versa, we evaluated the usefulness of total serum IgE and allergen specific IgE. In our study, 40-60% of patients with normal IgE were negative for allergy which is in agreement with the study done by Rame Khasawneh et al. in Jordan which emphasized 44% of cases with normal Total IgE do not indicate absence of allergy and 20% of cases with high level of Total IgE do not indicate an allergy.6 The probability of allergic reaction is high when the level of Specific IgE is high as the specific B cells are induced when allergens enter the body. Therefore, increased Specific IgE lead to increase in Total Ige. However, the level of specific IgE should be high enough to have a direct impact on Total IgE.16

Our study showed prevalence of dust allergy was 62.18%, insect allergen was 52.69%, and food allergy was 51.78%. House dust mite (58.90%) was seen to be most common. Among the insect allergy group, mosquito had the highest positive rate of 60% followed by Cockroach (52.58%). Incidence of food allergy was highest in the 0-3 year’s age group. Amongst these, egg yolk allergies were highest (26.95%) followed by cow milk (25.51%). Food allergens such as Plaice fish (31.25%) and Pecan nut caused the highest allergy amongst 7-12 years age group. Dust and insect allergens are common in patients affected by Allergic Rhinitis and are the main causes of Allergic Rhinitis and Allergic Asthma.7, 17 In India alone, 20 to 30% of the population suffer from Allergic Rhinitis while global prevalence is around 15 to 30%.17 Allergic disorders may be high owing to the diverse geographical area and seasonal variation.17 Also smoking, drinking habits, pets and family history were common in Asian countries while focus is more on effects of pollens, drugs pets, and family history in western countries.18

Most common allergens reported were comparable to a study by Kammili Jyothirmayi et al. from Bengaluru, South India which reported highest prevalence of dust mite (32.48%) followed by pollens (27.48%).17 This was coherent with a Jordanian study by Rame Khasawneh et al. who reported total house dust mite allergy as 24.2% (13.6% - dermatophagoides pteronyssinus, 10.6% - dermatophagoides farina) followed by grass mix and pollens 20.3% (grass mix- 12.8%, grass pollen- 7.5%) and cat 10.6%.6

Asthma symptoms were more prevalent in developed countries. Some areas in Africa and the Indian Subcontinent had the lowest prevalence. This may be due to genetic factors and changing environmental exposure in Asia & Africa.19

As per our study, Cow’s milk allergy was 25.5% until 3 years of age which reduces to 15.5% by the sixth year of life. This bores resemblance to a study conducted in New York, USA by Sampson HA et al. who states that Cow’s milk allergy affects 2.5% newborns in the first year of life who outgrow them by the third year.20 This is also supported by a pediatric Japanese study by Uriso et al. which states that the number of patients decreases with increase in age for common causative food items like eggs, wheat, dairy products, buckwheat, shrimp and peanuts.21 A slower maturation of the immune response that normally occurs during the initial 12 to 18 months of life is what predisposes a child to the subsequent development of allergy and asthma.21 Some epidemiological studies have shown a link between hygiene hypothesis and Immune response while in some studies there is no link.22

As physical, biochemical and immunological barriers are underdeveloped during the initial period of life, allergy to food is very common in pediatric age group. Currently management of allergy involves avoidance of the causative allergen and therapeutic remedy in case of unintended contact or ingestion. As allergy is a lifelong chronic condition, avoidance can be challenging and sometimes it is difficult to identify the allergen. Coping with allergy symptoms create a burden in day-to-day life contributing to poorer quality of life.14

Limitations

Clinical condition and treatment history for allergic symptoms was not available.

False positive results may occur in low positive IgE results (0.35 kUA/L– 3.00 kUA/L) due to cross-reactive carbohydrate determinant (CCD) interference in assays. Using a non cellulose based assay or a (CCD) inhibitor can alleviate CCD-IgE interference.23

Conclusion

The growing prevalence of allergy and asthma in India has become a major health concern with symptoms ranging from mild rhinitis to severe asthma and even life-threatening anaphylaxis. We found that house dust mite allergen has been recorded to have the highest prevalence in Indian population followed by food and insect allergies. Total IgE and specific IgE can never replace each other, however combining the two tests together along with clinical manifestations will improve the interpretation. The positive correlation between IgE and specific IgE was found to around 95% in our study however 13% were negative for Total IgE but positive for specific IgE. Hence, it is proposed to test for clinically appropriate allergen specific IgE tests, regardless of Total IgE concentration in patients with a history of an acute allergic reaction to know the cause of allergy. The availability of multiple and allergen specific panels has proved to be a major tool for the detection and diagnosis of multiple allergies. Detection of allergy is necessary to avoid wrong diagnosis and mismanagement of disease. It is necessary to increase awareness and educate our healthcare workers and patients regarding allergy testing to propagate information to patients and caregivers. Partnering with regional, national, and international allergy societies may help to flatten the allergy epidemic curve.

Source of Funding

None.

Conflict of Interest

None.

References

1 

R Prasad R Kumar Allergy Situation in India: What Is Being Done?Indian J Chest Dis Allied Sci201355178

2 

SJ Galli M Tsai AM Piliponsky The Development of Allergic InflammationNature20084544455410.1038/nature07204

3 

K Bhattacharya G Sircar A Dasgupta SG Bhattacharya Spectrum of Allergens and Allergen Biology in IndiaInt Arch Allergy Immunol2018177321937

4 

S Sicherer H Sampson Food AllergyJ Allergy Clin Immunol200611794705

5 

BJH Dierick TVD Molen BMJ Flokstra-De Blok A Muraro MJ Postma JWH Kocks Burden and Socioeconomics of Asthma, Allergic Rhinitis, Atopic Dermatitis and Food AllergyExpert Rev Pharmacoecon Outcomes Res202020543753

6 

R Khasawneh M Hiary B Abadi AB Salameh S Moman Total and Specific Immunoglobulin E for Detection of Most Prevalent Aeroallergens in a Jordanian CohortMed Arch20197342725

7 

A Almatroudi AM Mousa D Vinnakota A Abalkhail ASS Alwashmi A Almatroodi Prevalence and Associated Factors of Respiratory Allergies in the Kingdom of Saudi Arabia: A Cross-Sectional InvestigationPLoS One2021236e025355810.1371/journal.pone.0253558

8 

MT Krishna PA Mahesh P Vedanthan S Moitra V Mehta DJ Christopher An Appraisal of Allergic Disorders in India and an Urgent Call for ActionWorld Allergy Organ J202013710044610.1016/j.waojou.2020.100446

9 

NE Eriksson Allergy Screening with Phadiatop® and CAP Phadiatop® in Combination with a Questionnaire in Adults with Asthma and RhinitisAllergy199045428592

10 

Directions for use 52-5256-EN/08. Phadia AB ImmunoCAP Specific IgE Conjugate 100 and 400-January 2011. Document Version 05https://dfu.phadia.com/Data/Pdf/5dae9e2489c23208b8036206.pdf

11 

L Soderstrom A Kober S Ahlstedt H Groot CE Lange R Paganelli A further evaluation of the clinical use of specific IgE antibody testing in allergic diseasesAllergy20035899218

12 

J Nitin P Revathi N Shradha J Vaibhav K Kowshik R Manoharan Severity and Risk Factors of Allergic Disorders among People in South IndiaAfr Health Sci20161612019

13 

S Enroth I Dahlbom T Hansson Å Johansson U Gyllensten Prevalence and sensitization of atopic allergy and coeliac disease in the Northern Sweden Population Health StudyInt J Circumpolar Health201372110.3402/ijch.v72i0.21403

14 

S Seité AMS Kuo .-S Taieb TL Strugar P Lio Self-Reported Prevalence of Allergies in the USA and Impact on Skin-an Epidemiological Study on a Representative Sample of American AdultsInt J Environ Res Public Health202017103360

15 

E Jensen-Jarolim Gender Effects in Allergology - Secondary Publications and UpdateWorld Allergy Organ J20171014710.1186/s40413-017-0178-8

16 

ML Chang C Cui YH Liu LC Pei B Shao Analysis of Total Immunoglobulin E and Specific Immunoglobulin E of 3,721 Patients with Allergic DiseaseBiomed Rep2015345737

17 

K Jyothirmayi P Kumar Analysis of Distribution of Allergens and Its Seasonal Variation in Allergic RhinitisJ Med Sci2019535962

18 

SN Chong FT Chew Epidemiology of allergic rhinitis and associated risk factors in AsiaWorld Allergy Organ J201811117

19 

GWK Wong TF Leung FWS Ko Changing Prevalence of Allergic Diseases in the Asia-Pacific RegionAllergy Asthma Immunol Res2013552517

20 

HA Sampson Utility of Food-Specific IgE Concentrations in Predicting Symptomatic Food AllergyJ Allergy Clin Immunol200110758916

21 

A Urisu M Ebisawa K Ito Y Aihara S Ito M Mayumi Japanese Guideline for Food Allergy 2014Allergol Int2014633399419

22 

Z Chad Allergies in childrenPaediatr Child Health20016855566

23 

E Sinson C Ocampo C Liao S Nguyen L Dinh K Rodems Cross-Reactive Carbohydrate Determinant Interference in Cellulose-Based IgE Allergy Tests Utilizing Recombinant Allergen ComponentsPlos One2020154e023134410.1371/journal.pone.0231344



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

2-13


Authors Details

Flavia J Almeida*, Jasmin Surana, Alap Christy, Raj Jatale, Shibani Ramchandani


Article History

Received : 07-02-2023

Accepted : 20-02-2023


Article Metrics


View Article As

 


Downlaod Files